OHZORA PUBLISHING
OHZORA PUBLISHING
Industry:
Printing Publishing
Founded:
1993-01-10
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.ohzora.co.jp
Total Employee:
11+
Status:
Active
Contact:
03-6778-5700
Technology used in webpage:
SPF Domain Not Resolving Twitter Timeline NTT PC Communications MuuMuu DNS
Current Employees Featured
Official Site Inspections
http://www.ohzora.co.jp Semrush global rank: 4.05 M Semrush visits lastest month: 3.02 K
- Host name: ohzora.co.jp
- IP address: 119.245.153.38
- Location: Taito Japan
- Latitude: 35.7033
- Longitude: 139.7905
- Timezone: Asia/Tokyo
- Postal: 111-0051
More informations about "Ohzora Publishing"
Ohzora Publishing | Manga Wiki - Fandom
Ohzora Publishing - Crunchbase Company Profile & Funding
Ohzora Publishing produces comic magazines for women. Tokyo, Tokyo, Japan; 11-50; Private; ohzora.jp ; 1,085,633; HighlightsSee details»
OHZORA PUBLISHING, CO. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for OHZORA PUBLISHING, CO. of CHIYODA-KU, TOKYO. Get the latest business insights from Dun & โฆSee details»
Ohzora Publishing - Wikiwand
Ohzora Publishing, Inc. (ๅฎๅบ็), also known as Ohzora Shuppan [2] is a josei manga publisher in Japan, [3] founded in 1990. Headquartered in Tokyo, Japan, it publishes Japanese manga, โฆSee details»
Ohzora Publishing - Overview, News & Competitors - ZoomInfo
View Ohzora Publishing (www.ohzora.co.jp) location in Tokyo, Japan , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Long-term safety and efficacy of anti-TNF multivalent VHH โฆ
A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock Locked padlock icon ... The OHZORA and NATSUZORA trials โฆSee details»
Category:Ohzora Publishing manga - Wikipedia
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn moreSee details»
Ohzora Publishing - Wikidata
Ohzora Publishing (Q3079528) From Wikidata. Jump to navigation Jump to search. josei manga publisher in Japan. edit. Language Label Description Also known as; English: Ohzora โฆSee details»
ลzora (disambiguation) - Wikipedia
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn moreSee details»
Efficacy and safety of the anti-TNF multivalent NANOBODY
Oct 5, 2022 As in other studies, the 52-week results from the OHZORA trial are limited by selection bias over time and the absence of a placebo or control group beyond 24 weeks. โฆSee details»
Ozoralizumab: First Approval | Drugs - Springer
Dec 13, 2022 Ozoralizumab was generally well tolerated in the 52-week OHZORA and NATSUZORA trials, and the majority of adverse events were mild or moderate in severity [5, โฆSee details»
Data from Japan's First Phase II/III Clinical Trial of NANOBODY ...
Dec 20, 2021 The OHZORA study was a randomized, placebo-controlled, double-blind study in 381 patients with active RA who have had an inadequate response to methotrexate (MTX) โฆSee details»
Ozoralizumab: first Nanobody® therapeutic for rheumatoid arthritis
Jul 11, 2023 In the OHZORA trial [Citation 32, Citation 33], the efficacy of subcutaneous administration of ozoralizumab every 4 weeks for 52 weeks under concomitant use of MTX โฆSee details»
Efficacy and pharmacokinetics of ozoralizumab, an anti-TNFฮฑ โฆ
Apr 13, 2023 Ozoralizumab (OZR), a tumor necrosis factor alpha (TNFฮฑ) inhibitor, is a NANOBODY® compound that binds to TNFฮฑ and human serum albumin. The main objective โฆSee details»
Long-term safety and efficacy of anti-TNF multivalent VHH โฆ
Objectives This study aimed to evaluate the long-term safety and efficacy profiles of ozoralizumab in patients with rheumatoid arthritis (RA) from the OHZORA, NATSUZORA and HOSHIZORA โฆSee details»
Long-term safety and efficacy of anti-TNF multivalent VHH
Aug 22, 2024 Objectives: This study aimed to evaluate the long-term safety and efficacy profiles of ozoralizumab in patients with rheumatoid arthritis (RA) from the OHZORA, NATSUZORA โฆSee details»
Efficacy and pharmacokinetics of ozoralizumab, an anti-TNFฮฑ
Apr 13, 2023 Methods: Efficacy data were analyzed from the OHZORA trial, in which OZR 30 or 80 mg was administered to Japanese patients with RA at 4-week intervals for 52 weeks in โฆSee details»
Efficacy and pharmacokinetics of ozoralizumab, an anti-TNFฮฑ โฆ
PK profile and effects of patient baseline characteristics on plasma concentration. In the OHZORA trial, the plasma concentration of OZR reached the C max at 144 h (median t max, 6 days) and โฆSee details»
Ozoralizumab - Drug Targets, Indications, Patents - Synapse
Nov 21, 2024 In December 2021, Taisho Pharmaceuticals presented the interim results from a 24-week administration in Phase II/III clinical trial (OHZORA study) of ozoralizumab in adult โฆSee details»